NASDAQ:CNTX
Context Therapeutics Inc.
- Stock
industry
Biotechnologyexchange
NASDAQ Capital Marketwebsite
www.contexttherapeutics.comipo date
Jul 28, 2021full time employees
9currency
USD
Context Therapeutics Inc., a clinical-stage biopharmaceutical company, develops products for the treatment of cancer for women in the United States. Its lead product candidate is onapristone extended release (ONA-XR), a potent and selective antagonist of the progesterone receptor that is linked to r...Show More
Earnings
Earnings per Share (Estimate*)
Revenue (Estimate*)
*Estimate based on analyst consensus